Skip to content

Clinical trials

Cholangiocarcinoma trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Brazil Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20192
20221
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Active, not recruiting2
Terminated2
Completed1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
AstraZeneca1
EMD Serono Research & Development Institute, Inc.1
Hospital de Clinicas de Porto Alegre1
Instituto do Cancer do Estado de São Paulo1
Jazz Pharmaceuticals1
Merck Sharp & Dohme LLC1
Taiho Oncology, Inc.1
Weill Medical College of Cornell University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma9
Gallbladder Neoplasms5
Bile Duct Neoplasms4
Biliary Tract Neoplasms4
Carcinoma, Ovarian Epithelial2
Adenocarcinoma of Lung1
Adrenal Gland Neoplasms1
Anus Neoplasms1
Camurati-Engelmann Syndrome1
Carcinoma, Adenoid Cystic1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.